VENT-03

N/A

Report date: 2026/03/12 20:00:16
NMEFirst In Class

Base Information

Drug NameVENT-03
Drug Alias NameCyclic GMP-AMP synthase (cGAS) inhibitor program(Ventus Therapeutics)VENT-03
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclic GMP-AMP synthase inhibitors
TargetsCyclic GMP-AMP synthase
Therapy Area/IndicationsInflammationImmune System DiseasesSkin Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBulgariaUnited StatesPoland +[9] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesVentus Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesVentus Therapeutics US IncVentus Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsInflammationSkin DiseasesLupus Erythematosus, Systemic +[4] 
Inactive IndicationsImmune System Diseases

Other Information

ATC CodeN/A
Related LinksN/A